Home › Therapeutic areas › Infectious Disease › Chronic Hepatitis Delta
Chronic Hepatitis Delta (1 companies)
Companies with an active program in Chronic Hepatitis Delta.
| Ticker | Company | Therapeutic areas | Programs | Lead stage | Mkt cap | Programs |
|---|---|---|---|---|---|---|
| VIR | Vir Biotechnology | Infectious DiseaseOncology Rare | 1 | Phase 3 | $2.09B | 12 |
No companies match.